Lowest Price Guaranteed From USD 4,799
Published
August 2023
Pages
323
View Count
37345
Example Insights
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Report Description
The global pre-sterilized / ready to use pharmaceutical packaging market is estimated to be worth USD 9.01 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 6.62%, during the forecast period. In the pharmaceutical industry, the integrity and safety of drugs and vaccines are of utmost importance. The primary packaging of such products plays an important role in ensuring their quality and protecting them from contaminants. Therefore, sterilization is crucial in pharmaceutical manufacturing as it helps to maintain product safety and uphold stringent quality standards. This has led to the emergence of pre-sterilized / ready to use containers and closures in pharmaceutical packaging. Ready to use vials, also known as RTU vials eliminate the need for in-house sterilization processes, reducing contamination risks and production timelines. It is worth noting that the increasing demand for safe drug delivery systems has driven the growth of the global pharmaceutical packaging market. As a result, ready-to-use components, such as sterile vials and sterile syringes have gained popularity, owing to their convenience and reliability across various applications. Advancements in technology have further contributed to the development of innovative packaging solutions that ensure product integrity and patient safety. Sterile primary containers are a growing segment within the pharmaceutical packaging market. Companies, such as Thermo Fisher Scientific and Corning Incorporated have developed various innovative primary packaging solutions, including pre-sterilized / ready to use containers and closures. These solutions ensure product quality, meet regulatory requirements, and streamline manufacturing processes. The increasing adoption of sterile vials and other sterile primary containers is likely to contribute significantly towards the robust growth of pre-sterilized / ready to use pharmaceutical packaging market size during the forecast period.
The Pre-Sterilized / Ready to Use Pharmaceutical Primary Packaging Market: Distribution by Type of Container (Sterile Cartridges, Sterile Syringes and Sterile Vials), Type of Closure (Caps, Plungers, Seals, Stoppers, Tip Caps / Needle Shields), Material of Fabrication (Aluminum, Glass, Plastic and Rubber) and Key Geographical Regions (North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, 2023 - 2035 report features an extensive study of the current market landscape, market size and future opportunity for the companies providing pre-sterilized / ready to use containers and closures, during the forecast period. Key inclusions of the report are briefly discussed below.
Owing to their numerous advantages, there is a growing demand for pre-sterilized / ready to use pharmaceutical primary packaging. The RTU containers and closures enhance time and cost efficiency by eliminating the need for sterilization equipment and associated expenses. Moreover, they improve productivity by streamlining the packaging process, while ensuring compliance to stringent quality standards and regulations. Additionally, the benefits offered by empty sterile vials and sterile syringes, and their growing demand in the healthcare sector, specifically post the pandemic has prompted stakeholders to implement advancements that are likely to drive market growth in the forecast period.
The current landscape of pre-sterilized / ready to use pharmaceutical primary packaging features close to 95 RTU containers and 85 RTU closures. It is worth mentioning that, amongst pre-sterilized / RTU containers, 43% of the primary packaging is empty sterile vials; 10 are ready to use cartridges. The majority of the containers are glass vials, primarily made of borosilicate glass. Several manufacturers offer sterile vials to meet the growing demand for aseptic filling of parenteral drugs. In February 2023, Nexus Pharmaceuticals introduced its line of sterile vials. These vials can store different liquid volumes (20 ml, 10 ml, and 2 ml). In March 2022, SGD Pharma launched a 100 ml ready to use sterile glass vial, catering to the demand for small and large sterile vials. Further, in June 2022, Schott invested multi-million euros to increase the production of sterile RTU vials at its facility located in Pennsylvania, US. Such expansions reflect the rising demand for RTU primary containers for parenteral drugs.
Recent trends and advancements in packaging materials and technologies have led to the emergence of innovative packaging solutions that offer enhanced drug compatibility, stability, and barrier properties. These solutions are made of high-quality medical polymers, elastomers, and glass compositions that are customized according to specific drug formulations. Furthermore, in order to increase patient convenience and medication adherence, there is a growing emphasis on simpler designs, such as integrated delivery systems and child-resistant closures. Such developments demonstrate the industry's dedication in producing efficient RTU primary packaging technologies that satisfy the diverse patient needs.
Another development supporting the growth of ready to use primary pharmaceutical packaging market includes the launch of fill / finish machines that are capable of de-nesting, filling, and closing RTU vials, syringes, and cartridges. This has led to the increasing usage of robotic systems in the drug development processes, thereby enhancing flexibility and reproducibility in the production process. Further, given the increasing focus on the development of personalized therapies for smaller patient population, drug manufacturers are prompted to adopt modern technology-based solutions, such as robotics, in order to augment the production of higher number of small batches in different packaging formats.
Several stakeholders have been forging alliances related to RTU primary packaging with other industry / non-industry players for product / technology integration, distribution, product development and technology licensing purposes. It is interesting to note that in February 2023, West Pharmaceutical Services entered into an agreement with Corning focused on the distribution of Corning Valor® Glass vials and West Ready Pack™; these systems employ Corning Valor® RTU vials and SG EZ-fill® technology. The West Ready Pack™ incorporates stoppers and seals provided by West Pharmaceutical Services, in addition to the Valor® RTU Vials supplied by Corning Incorporated.
Presently, close to XX% of the market is captured by companies based in North America. Due to the increasing interest of stakeholders in pharmaceutical packaging, the pre-sterilized / ready to use containers and closures market is expected to experience substantial growth in the forecast period. The market is expected to witness a steady compound annual growth rate (CAGR) of XX% during the period 2023-2035. Notably, in the long term, the market size in Asia is anticipated to grow at a relatively faster pace. This increase can be attributed to the expanding population of the region, thereby increasing the demand for healthcare products. In addition, factors, such as healthcare infrastructure, favorable government initiatives and investments in the pharmaceutical sector are likely to drive the growth opportunities in Asia, in the long term.
The pre-sterilized or ready to use pharmaceutical packaging market is driven by multiple factors. One of the primary drivers is the growing emphasis on patient safety, which involves ensuring the sterility and integrity of pharmaceutical products. The strict regulatory guidelines and compliance standards established by regulatory agencies, such as the FDA and EMA, also play an important role in driving the demand for pre-sterilized packaging. In addition, the increasing complexity of drug products, such as cell and gene therapies has created the demand for primary containers that are suitable for aseptic fill and finish of ATMPs. The integration of RTU (ready to use) packaging containers within the pharmaceutical industry enables swift product launch through an optimized value chain.
Further, the huge increase in the demand for COVID-19 vaccines has pushed the market growth, specifically for sterile vials. In March 2022, Stevanato expanded its vial manufacturing operations under a contract with the Biomedical Advanced Research and Development Authority (BARDA) to meet the need for vaccines, during the pandemic. The company invested in scaling up the production capacity of its standard RTU vials and EZ fill RTU vials.
Examples of key players (which have also been profiled in this report) manufacturing pre-sterilized / ready to use containers and closures include (in alphabetical order) APG Pharma Packaging, Aptar, Daikyo Seiko, Datwyler, DWK Life Sciences, Ningbo Zhengli Pharmaceutical Packaging, Nuova OMPI (a subsidiary of Stevanato), SCHOTT and West Pharmaceutical Services.
Several recent developments have taken place in the field of pharmaceutical primary packaging. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The market report features an in-depth analysis of various firms / organizations that are engaged in this industry, across different segments as defined in the below table:
| Key Report Attributes | Details | |
|
Base Year |
2023 |
|
|
Historical Period |
2018 – 2021 |
|
|
Base Year |
2022 |
|
|
Forecast Period |
2023 – 2035 |
|
|
Market Size 2023 |
$9.01 Billion |
|
|
CAGR |
6.62% |
|
|
Type of Container |
|
|
|
Type of Closure |
|
|
|
Material of Fabrication |
|
|
|
Key Geographical Regions |
|
|
|
Key Companies Profiled |
|
|
|
PowerPoint Presentation (Complimentary) |
|
|
|
Customization Scope |
|
|
|
Excel Data Packs (Complimentary) |
|
|
The market research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the report includes:
One of the key objectives of the market report was to estimate the current opportunity and future growth potential of pre-sterilized / ready to use pharmaceutical packaging market over the coming years. We have provided informed estimates on the likely evolution of the market for the forecast period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of container (sterile cartridges, sterile syringes, sterile vials), type of closure (caps, plunger, seals, stoppers and tip caps / needle shields), material of fabrication (aluminum, glass, plastic and rubber) and key geographical regions (North America, Europe, Asia, Latin America, Middle East and North Africa, and Rest of the World). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.
The opinions and insights presented in this market analysis were influenced by discussions conducted with multiple stakeholders in this industry. The report features detailed transcripts of interviews held with the following individuals:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
1. PREFACE
1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Inclusions and Exclusions
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Pharmaceutical Packaging and Filling
5.2.1. Need for Pharmaceutical Packaging
5.2.2. Types of Pharmaceutical Packaging
5.2.3. Limitations of Traditional Primary Packaging
5.2.4. Innovation in Pharmaceutical Packaging
5.3. Ready to Use Primary Packaging
5.3.1. Sterilization Techniques used in Primary Packaging
5.3.2. Advantages of Ready to Use Primary Packaging
5.3.3. Cost Saving Opportunities in Ready to Use Primary Packaging
5.3.4. Current Demand for Ready to Use Primary Packaging
5.4. Concluding Remarks
6. PRE-STERILIZED / READY TO USE CONTAINERS: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Pre-Sterilized / Ready to Use Containers: Overall Market Landscape
6.2.1. Analysis by Type of Container
6.2.2. Analysis by Material(s) of Fabrication
6.2.3. Analysis by Container Color
6.2.4. Analysis by Type of Compatible Drug(s)
6.2.5. Analysis by Scale of Operation
6.2.6. Analysis by Packaging Format(s)
6.2.7. Analysis by Sterilization Technique(s) Used
6.2.8. Analysis by Quality Certification(s) Obtained
6.2.9. Analysis by Target Market
6.2.10. Analysis by Availability of Additional Coating
6.2.11. Analysis by Availability of RTU Kits
6.3. Pre-Sterilized / Ready to Use Containers: Manufacturer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Leading Manufacturers: Analysis by Number of Products
7. PRE-STERILIZED / READY TO USE CLOSURES: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Pre-Sterilized / Ready to Use Closures: Overall Market Landscape
7.2.1. Analysis by Type of Closure
7.2.2. Analysis by Material(s) of Fabrication
7.2.3. Analysis by Type of Compatible Container(s)
7.2.4. Analysis by Type of Compatible Drug(s)
7.2.5. Analysis by Sterilization Technique(s) Used
7.2.6. Analysis by Available Finish Format(s)
7.2.7. Analysis by Quality Certification(s) Obtained
7.2.8. Analysis by Target Market
7.2.9. Analysis by Availability of Additional Coating
7.3. Pre-Sterilized / Ready to Use Closures: Manufacturer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.3.4. Leading Manufacturers: Analysis by Number of Products
8. KEY INSIGHTS
8.1. Chapter Overview
8.2. Pre-Sterilized / Ready to Use Containers: Key Insights
8.2.1. Analysis by Type of Container and Scale of Operation
8.2.2. Analysis by Type of Container and Packaging Format(s)
8.2.3. Analysis by Type of Container and Material(s) of Fabrication
8.2.4. Analysis by Type of Container and Container Color
8.2.5. Analysis by Type of Container and Sterilization Technique(s) Used
8.2.6. Analysis by Type of Container and Type of Compatible Drug(s)
8.2.7. Analysis by Material(s) of Fabrication and Sterilization Technique(s) Used
8.3. Pre-Sterilized / Ready to Use Closures: Key Insights
8.3.1. Analysis by Type of Closure and Material(s) of Fabrication
8.3.2. Analysis by Type of Closure and Sterilization Technique(s) Used
8.3.3. Analysis by Type of Closure and Available Finish Format(s)
8.3.4. Analysis by Type of Closure and Type of Compatible Drug(s)
9. PRODUCT COMPETITIVENESS ANALYSIS: PRE-STERILIZED / READY TO USE CONTAINERS
9.1. Chapter Overview
9.2. Pre-Sterilized / Ready to Use Containers: Product Competitiveness Analysis
9.2.1. Assumptions and Key Parameters
9.2.2. Methodology
9.2.3. Product Competitiveness Analysis: Vials
9.2.4. Product Competitiveness Analysis: Syringes
9.2.5. Product Competitiveness Analysis: Bags
9.2.6. Product Competitiveness Analysis: Cartridges
10. PRODUCT COMPETITIVENESS ANALYSIS: PRE-STERILIZED / READY TO USE CLOSURES
10.1. Chapter Overview
10.2. Pre-Sterilized / Ready to Use Closures: Product Competitiveness Analysis
10.2.1. Assumptions and Key Parameters
10.2.2. Methodology
10.2.3. Product Competitiveness Analysis: Stoppers
10.2.4. Product Competitiveness Analysis: Plungers
10.2.5. Product Competitiveness Analysis: Caps
10.2.6. Product Competitiveness Analysis: Tip Caps / Needle Shields
10.2.7. Product Competitiveness Analysis: Seals
11. COMPANY PROFILES
11.1. Chapter Overview
11.2. APG Pharma Packaging
11.2.1. Company Overview
11.2.2. Product Portfolio
11.2.2.1. Ready to Use Closures
11.2.3. Recent Developments and Future Outlook
11.3. Aptar
11.3.1. Company Overview
11.3.2. Financial Information
11.3.3. Product Portfolio
11.3.3.1. Ready to Use Closures
11.3.4. Recent Developments and Future Outlook
11.4. Daikyo Seiko
11.4.1. Company Overview
11.4.2. Product Portfolio
11.4.2.1. Ready to Use Containers
11.4.2.2. Ready to Use Closures
11.4.3. Recent Developments and Future Outlook
11.5. Datwyler
11.5.1. Company Overview
11.5.2. Financial Information
11.5.3. Product Portfolio
11.5.3.1. Ready to Use Closures
11.5.4. Recent Developments and Future Outlook
11.6. DWK Life Sciences
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.2.1. Ready to Use Containers
11.6.2.2. Ready to Use Closures
11.6.3. Recent Developments and Future Outlook
11.7. Ningbo Zhengli Pharmaceutical Packaging
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.2.1. Ready to Use Containers
11.7.3. Recent Developments and Future Outlook
11.8. SCHOTT
11.8.1. Company Overview
11.8.2. Financial Information
11.8.3. Product Portfolio
11.8.3.1. Ready to Use Containers
11.8.3.2. Ready to Use Closures
11.8.4. Recent Developments and Future Outlook
11.9. Stevanato
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.2.1. Ready to Use Containers
11.9.2.2. Ready to Use Closures
11.9.3. Recent Developments and Future Outlook
11.10. West Pharmaceutical Services
11.10.1. Company Overview
11.10.2. Financial Information
11.10.3. Product Portfolio
11.10.3.1. Ready to Use Containers
11.10.3.2. Ready to Use Closures
11.10.4. Recent Developments and Future Outlook
12. PARTNERSHIPS AND COLLABORATIONS
12.1. Chapter Overview
12.2. Partnership Models
12.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging: Partnerships and Collaborations
12.3.1. Analysis by Year of Partnership
12.3.2. Analysis by Type of Partnership
12.3.3. Analysis by Year and Type of Partnership
12.3.4. Analysis by Type of Partner
12.3.5. Analysis by Year of Partnership and Type of Partner
12.3.6. Analysis by Type of Partnership and Type of Partner
12.3.7. Analysis by Purpose of Partnership
12.3.8. Analysis by Type of Packaging System
12.3.9. Analysis by Type of Packaging Material
12.3.10. Most Active Players: Analysis by Number of Partnerships
12.3.11. Analysis by Geography
12.3.11.1. Intercontinental and Intracontinental Deals
13. MARKET ENTRY DECISION MAKING FRAMEWORK
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Key Parameters Impacting Market Entry Decision Making
13.3.1. Product Reach
13.3.2. Product Differentiation
13.3.3. Market Activity
13.3.4. Product Competitiveness
13.3.5. Manufacturing Complexity
13.4. Concluding Remarks
14. DEMAND ANALYSIS
14.1. Chapter Overview
14.2. Scope and Methodology
14.3. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Type of Container
14.3.1. Pre-Sterilized / Ready to Use Vials, 2023-2035
14.3.2. Pre-Sterilized / Ready to Use Syringes, 2023-2035
14.3.3. Pre-Sterilized / Ready to Use Cartridges, 2023-2035
14.4. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Type of Closure
14.4.1. Pre-Sterilized / Ready to Use Caps, 2023-2035
14.4.2. Pre-Sterilized / Ready to Use Plungers, 2023-2035
14.4.3. Pre-Sterilized / Ready to Use Seals, 2023-2035
14.4.4. Pre-Sterilized / Ready to Use Stoppers, 2023-2035
14.4.5. Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, 2023-2035
14.5. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Material of Fabrication
14.5.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Aluminum Containers and Closures, 2023-2035
14.5.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Glass Containers and Closures, 2023-2035
14.5.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Plastic Containers and Closures, 2023-2035
14.5.4. Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Rubber Containers and Closures, 2023-2035
14.6. Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Geography
14.6.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, 2023-2035
14.6.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, 2023-2035
14.6.3. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, 2023-2035
14.6.4. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, 2023-2035
14.6.5. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, 2023-2035
14.6.6. Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, 2023-2035
15. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
15.1. Chapter Overview
15.2. Market Drivers
15.3. Market Restraints
15.4. Market Opportunities
15.5. Market Challenges
15.6. Conclusion
16. GLOBAL PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET
16.1. Chapter Overview
16.2. Assumptions and Methodology
16.3. Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.1. Scenario Analysis
16.4. Key Market Segmentations
16.5. Dynamic Dashboard
17. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY TYPE OF CONTAINER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Vials: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Cartridges: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.6. Data Triangulation and Validation
18. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY TYPE OF CLOSURE
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Caps: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Plungers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Seals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.6. Stoppers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.7. Tip Caps / Needle Shields: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.8. Data Triangulation and Validation
19. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY MATERIAL OF FABRICATION
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Aluminum Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.4. Glass Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.5. Plastic Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.6. Rubber Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.7. Data Triangulation and Validation
20. PRE-STERILIZED / READY TO USE PHARMACEUTICAL PACKAGING MARKET, BY GEOGRAPHY
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.3.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
20.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.4.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
20.5. Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.5.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
20.6. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.6.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.6.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
20.7. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.7.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.7.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
20.8. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.7.1. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers
20.7.2. Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures
20.9. Data Triangulation and Validation
21. EMERGING TRENDS IN PHARMACEUTICAL PACKAGING
21.1. Chapter Overview
21.2. Emerging Trends
21.2.1. Preference for Self-Medication of Drugs using Modern Drug Delivery Devices
21.2.2. Development of Improved Packaging Components and Efforts to Optimize Manufacturing Costs
21.2.3. Availability of Modular Facilities
21.2.4. Growing Demand and Preference for Personalized Therapies
21.2.5. Rise in Provisions for Automating Fill / Finish Operations
21.2.6. Surge in Partnership Activity
21.2.7. Increase in Initiatives Undertaken by Industry Stakeholders in Developing Regions
21.3. Concluding Remarks
22. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING
22.1. Chapter Overview
22.2. Role of Robotics in Pharmaceutical Industry
22.2.1. Key Considerations for Selecting a Robotic System
22.2.2. Advantages of Robotic Systems
22.2.3. Limitations of Robotic Systems
22.3. Companies Providing Robots for Use in Pharmaceutical Industry
22.4. Companies Providing Equipment Integrated Robotic Systems for Use in Pharmaceutical Packaging
22.4.1. Aseptic Technologies
22.4.1.1. Crystal L1 Robot Line
22.4.1.2. Crystal SL1 Robot Line
22.4.2. AST
22.4.2.1. ASEPTiCELL
22.4.2.2. GENiSYS R
22.3.2.3. GENiSYS C
22.3.2.4. GENiSYS Lab
22.4.3. Bosch Packaging Technology
22.4.3.1. ATO
22.4.4. Dara Pharma
22.4.4.1. SYX-E Cartridge + RABS
22.4.5. Fedegari
22.4.5.1. Fedegari Isolator
22.4.6. IMA
22.4.6.1. INJECTA
22.4.6.2. STERI LIF3
22.4.7. Steriline
22.4.7.1. Robotic Nest Filling Machine (RNFM)
22.4.7.2. Robotic Vial Filling Machine (RVFM)
22.4.7.3. Robotic Vial Capping Machine (RVCM)
22.4.8. Vanrx Pharmasystems
22.4.8.1. Microcell Vial Filler
22.4.8.2. SA25 Aseptic Filling Workcell
22.5. Concluding Remarks
23. CONCLUSION
24. EXECUTIVE INSIGHTS
24.1. Chapter Overview
24.2. Jinan Youlyy Industrial
24.2.1. Company Snapshot
24.2.2. Interview Transcript: Cara Qiu, Business Development Specialist
24.3. Sagar Rubber
24.3.1. Company Snapshot
24.3.2. Interview Transcript: Daxesh Shah, Founder and Managing Director
24.4. Aseptic Technologies
24.4.1. Company Snapshot
24.4.2. Interview Transcript: Julien Maréchal, Business Development and Technology Director
24.5. BioPhorum Operations
24.5.1. Company Snapshot
24.5.2. Interview Transcript: Malcolm Gilmore, Former Facilitator
24.6. PYRAMID Laboratories
24.6.1. Company Snapshot
24.6.2. Interview Transcript: Konstantin Kazarian, Former Project Manager of Business Development
25. APPENDIX 1: TABULATED DATA
26. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Pre-Sterilized / Ready to Use Containers Market Landscape
Figure 4.2 Executive Summary: Pre-Sterilized / Ready to Use Closures Market Landscape
Figure 4.3 Executive Summary: Partnerships and Collaborations
Figure 4.4 Executive Summary: Market Entry Decision Making Framework
Figure 4.5 Executive Summary: Demand Analysis
Figure 4.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Advantages of Pharmaceutical Packaging
Figure 5.2 Types of Pharmaceutical Packaging
Figure 5.3 Innovation in Pharmaceutical Packaging and Value Chain
Figure 5.4 Steps Involved in Flexible Aseptic Processing
Figure 5.5 Advantages of Ready to Use Platform
Figure 5.6 Drivers of Ready to Use Platform
Figure 6.1 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Container
Figure 6.2 Pre-Sterilized / Ready to Use Containers: Distribution by Material(s) of Fabrication
Figure 6.3 Pre-Sterilized / Ready to Use Containers: Distribution by Container Color
Figure 6.4 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Compatible Drug(s)
Figure 6.5 Pre-Sterilized / Ready to Use Containers: Distribution by Scale of Operation
Figure 6.6 Pre-Sterilized / Ready to Use Containers: Distribution by Packaging Format(s)
Figure 6.7 Pre-Sterilized / Ready to Use Containers: Distribution by Sterilization Technique(s) Used
Figure 6.8 Pre-Sterilized / Ready to Use Containers: Distribution by Quality Certification(s) Obtained
Figure 6.9 Pre-Sterilized / Ready to Use Containers: Distribution by Target Market
Figure 6.10 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of Additional Coating
Figure 6.11 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of RTU Kits
Figure 6.12 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Year of Establishment
Figure 6.13 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Company Size
Figure 6.14 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 6.15 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 6.16 Leading Manufacturers: Distribution by Number of Products
Figure 7.1 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Closure
Figure 7.2 Pre-Sterilized / Ready to Use Closures: Distribution by Material(s) of Fabrication
Figure 7.3 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Container(s)
Figure 7.4 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Drug(s)
Figure 7.5 Pre-Sterilized / Ready to Use Closures: Distribution by Sterilization Technique(s) Used
Figure 7.6 Pre-Sterilized / Ready to Use Closures: Distribution by Available Finish Format(s)
Figure 7.7 Pre-Sterilized / Ready to Use Closures: Distribution by Quality Certification(s) Obtained
Figure 7.8 Pre-Sterilized / Ready to Use Closures: Distribution by Target Market
Figure 7.9 Pre-Sterilized / Ready to Use Closures: Distribution by Availability of Additional Coating
Figure 7.10 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Year of Establishment
Figure 7.11 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Company Size
Figure 7.12 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 7.13 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 7.14 Leading Manufacturers: Distribution by Number of Products
Figure 8.1 Key Insights: Distribution by Type of Container and Scale of Operation
Figure 8.2 Key Insights: Distribution by Type of Container and Packaging Format(s)
Figure 8.3 Key Insights: Distribution by Type of Container and Material(s) of Fabrication
Figure 8.4 Key Insights: Distribution by Type of Container and Container Color
Figure 8.5 Key Insights: Distribution by Type of Container and Sterilization Technique(s) Used
Figure 8.6 Key Insights: Distribution by Type of Container and Type of Compatible Drug(s)
Figure 8.7 Key Insights: Distribution by Material(s) of Fabrication and Sterilization Technique(s) Used
Figure 8.8 Key Insights: Distribution by Type of Closure and Material(s) of Fabrication
Figure 8.9 Key Insights: Distribution by Type of Closure and Sterilization Technique(s) Used
Figure 8.10 Key Insights: Distribution by Type of Closure and Available Finish Format(s)
Figure 8.11 Key Insights: Distribution by Type of Closure and Type of Compatible Drug(s)
Figure 9.1 Product Competitiveness Analysis: Vials
Figure 9.2 Product Competitiveness Analysis: Syringes
Figure 9.3 Product Competitiveness Analysis: Bags
Figure 9.4 Product Competitiveness Analysis: Cartridges
Figure 10.1 Product Competitiveness Analysis: Stoppers
Figure 10.2 Product Competitiveness Analysis: Plungers
Figure 10.3 Product Competitiveness Analysis: Caps
Figure 10.4 Product Competitiveness Analysis: Tip Caps / Needle Shields
Figure 10.5 Product Competitiveness Analysis: Seals
Figure 11.1 Aptar: Annual Revenues, 2016-Q1 2023 (USD Billion)
Figure 11.2 Datwyler: Annual Revenues, 2016-2022 (CHF Billion)
Figure 11.3 SCHOTT: Annual Revenues, FY 2019-FY 2022 (EUR Billion)
Figure 11.4 West Pharmaceutical Services: Annual Revenues, 2018-2022 (USD Billion)
Figure 12.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2023
Figure 12.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 12.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 12.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 12.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, 2015-2023
Figure 12.6 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 12.7 Partnerships and Collaborations: Distribution by Purpose of Partnership
Figure 12.8 Partnerships and Collaborations: Distribution by Type of Packaging System
Figure 12.9 Partnerships and Collaborations: Distribution by Type of Packaging Material
Figure 12.10 Most Active Players: Distribution by Number of Partnerships
Figure 12.11 Partnerships and Collaborations: Local and International Agreements
Figure 12.12 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 13.1 Spider Web Analysis: Product Reach
Figure 13.2 Spider Web Analysis: Product Differentiation
Figure 13.3 Spider Web Analysis: Market Activity
Figure 13.4 Spider Web Analysis: Product Competitiveness
Figure 13.5 Spider Web Analysis: Manufacturing Complexity
Figure 13.6 Market Entry Decision Making Framework: Concluding Remarks
Figure 14.1 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Type of Container
Figure 14.2 Demand for Pre-Sterilized / Ready to Use Vials, 2023-2035
Figure 14.3 Demand for Pre-Sterilized / Ready to Use Syringes, 2023-2035
Figure 14.4 Demand for Pre-Sterilized / Ready to Use Cartridges, 2023-2035
Figure 14.5 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Type of Closure
Figure 14.6 Demand for Pre-Sterilized / Ready to Use Caps, 2023-2035
Figure 14.7 Demand for Pre-Sterilized / Ready to Use Plungers, 2023-2035
Figure 14.8 Demand for Pre-Sterilized / Ready to Use Seals, 2023-2035
Figure 14.9 Demand for Pre-Sterilized / Ready to Use Stoppers, 2023-2035
Figure 14.10 Demand for Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, 2023-2035
Figure 14.11 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Material of Fabrication
Figure 14.12 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Aluminum Containers and Closures, 2023-2035
Figure 14.13 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Glass Containers and Closures, 2023-2035
Figure 14.14 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Plastic Containers and Closures, 2023-2035
Figure 14.15 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Rubber Containers and Closures, 2023-2035
Figure 14.16 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Geography
Figure 14.17 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, 2023-2035
Figure 14.18 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, 2023-2035
Figure 14.19 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, 2023-2035
Figure 14.20 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, 2023-2035
Figure 14.21 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, 2023-2035
Figure 14.22 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, 2023-2035
Figure 16.1 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 16.2 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035: Optimistic Scenario
Figure 16.3 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035: Conservative Scenario
Figure 16.4 Dynamic Dashboard
Figure 17.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Vials: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 17.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 17.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Cartridges: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 18.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Caps: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 18.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plungers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 18.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Seals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 18.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Stoppers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 18.5 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Tip Caps / Needle Shields: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 19.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Aluminum Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 19.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Glass Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 19.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plastic Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 19.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Rubber Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.2 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.3 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.4 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.5 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.6 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.7 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.8 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.9 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.10 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.11 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.12 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.13 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.14 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.15 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.6 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.17 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 20.18 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 21.1 Emerging Trends in Pharmaceutical Packaging
Figure 21.2 Future Growth Opportunities for Ready to Use Containers and Closures Based on Recent Trends
Figure 22.1 Key Considerations for Selecting a Robotic System
Figure 22.2 Advantages of Robotic Systems
Figure 22.3 Limitations of Robotic Systems
Figure 23.1 Concluding Remarks: Market Landscape of Pre-Sterilized / Ready to Use Containers
Figure 23.2 Concluding Remarks: Market Landscape of Pre-Sterilized / Ready to Use Closures
Figure 23.3 Concluding Remarks: Partnerships and Collaborations
Figure 23.4 Concluding Remarks: Market Entry Decision Making Framework
Figure 23.5 Concluding Remarks: Demand Analysis
Figure 23.6 Concluding Remarks: Market Forecast
Table 5.1 Compatibility of Polymers with Ethylene Oxide Sterilization
Table 5.2 Advantages and Disadvantages of Different Sterilization Techniques
Table 6.1 Pre-Sterilized / Ready to Use Containers: Information on Type of Container, Material(s) of Fabrication, Container Color and Type of Compatible Drug(s)
Table 6.2 Pre-Sterilized / Ready to Use Containers: Information on Scale of Operation, Packaging Format(s) and Sterilization Technique(s) Used
Table 6.3 Pre-Sterilized / Ready to Use Containers: Information on Quality Certification(s) Obtained and Target Market
Table 6.4 Pre-Sterilized / Ready to Use Containers: Information on Availability of Additional Coating and RTU Kits
Table 6.5 Pre-Sterilized / Ready to Use Containers: List of Manufacturers
Table 7.1 Pre-Sterilized / Ready to Use Closures: Information on Type of Closure, Material(s) of Fabrication, Type of Compatible Container(s), Type of Compatible Drug(s) and Sterilization Technique(s) Used
Table 7.2 Pre-Sterilized / Ready to Use Closures: Information on Available Finish Format(s), Quality Certification(s) Obtained and Target Market
Table 7.3 Pre-Sterilized / Ready to Use Closures: Information on Availability of Additional Coating
Table 7.4 Pre-Sterilized / Ready to Use Closures: List of Manufacturers
Table 11.1 Pre-Sterilized / Ready to Use Pharmaceutical Packaging: List of Companies Profiles
Table 11.2 APG Pharma Packaging: Company Snapshot
Table 11.3 APG Pharma Packaging: Ready to Use Closures
Table 11.4 Aptar: Company Snapshot
Table 11.5 Aptar: Ready to Use Closures
Table 11.6 Aptar: Recent Developments and Future Outlook
Table 11.7 Daikyo Seiko: Company Snapshot
Table 11.8 Daikyo Seiko: Ready to Use Containers
Table 11.9 Daikyo Seiko: Ready to Use Closures
Table 11.10 Datwyler: Company Snapshot
Table 11.11 Datwyler: Ready to Use Closures
Table 11.12 Datwyler: Recent Developments and Future Outlook
Table 11.13 DWK Life Sciences: Company Snapshot
Table 11.14 DWK Life Sciences: Ready to Use Containers
Table 11.15 DWK Life Sciences: Ready to Use Closures
Table 11.16 DWK Life Sciences: Recent Developments and Future Outlook
Table 11.17 Ningbo Zhengli Pharmaceutical Packaging: Company Snapshot
Table 11.18 Ningbo Zhengli Pharmaceutical Packaging: Ready to Use Containers
Table 11.19 Ningbo Zhengli Pharmaceutical Packaging: Recent Developments and Future Outlook
Table 11.20 SCHOTT: Company Snapshot
Table 11.21 SCHOTT: Ready to Use Containers
Table 11.22 SCHOTT: Ready to Use Closures
Table 11.23 SCHOTT: Recent Developments and Future Outlook
Table 11.24 Stevanato: Company Snapshot
Table 11.25 Stevanato: Ready to Use Containers
Table 11.26 Stevanato: Ready to Use Closures
Table 11.27 Stevanato: Recent Developments and Future Outlook
Table 11.28 West Pharmaceutical Services: Company Snapshot
Table 11.29 West Pharmaceutical Services: Ready to Use Containers
Table 11.30 West Pharmaceutical Services: Ready to Use Closures
Table 11.31 West Pharmaceutical Services: Recent Developments and Future Outlook
Table 12.1 Pre-Sterilized / Ready-to-Use Containers and Closures: List of Partnerships and Collaborations, 2015-2023
Table 22.1 List of Pharmaceutical Robotic System Manufacturers
Table 22.2 Aseptic Technologies: Company Overview
Table 22.3 Aseptic Technologies: Key Specifications of Crystal L1 Robot Line
Table 22.4 Aseptic Technologies: Key Specifications of Crystal SL1 Robot Line
Table 22.5 AST: Company Overview
Table 22.6 AST: Key Specifications of ASEPTiCell
Table 22.7 AST: Key Specifications of GENiSYS R
Table 22.8 AST: Key Specifications of GENiSYS C
Table 22.9 AST: Key Specifications of GENiSYS Lab
Table 22.10 Bosch Packaging Technology: Company Overview
Table 22.11 Bosch Packaging Technology: Key Specifications of ATO
Table 22.12 Dara Pharma: Company Overview
Table 22.13 Dara Pharma: Key Specifications of SYX-E Cartridge + RABS
Table 22.14 Fedegari: Company Overview
Table 22.15 Fedegari: Key Specifications of Fedegari Isolator
Table 22.16 IMA: Company Overview
Table 22.17 IMA: Key Specifications of INJECTA
Table 22.18 IMA: Key Specifications of STERI LIF3
Table 22.19 Steriline: Company Overview
Table 22.20 Steriline: Key Specifications of Robotic Nest Filling Machine (RNFM)
Table 22.21 Steriline: Key Specifications of Robotic Vial Filling Machine (RVFM)
Table 22.22 Steriline: Key Specifications of Robotic Vial Capping Machine (RVCM)
Table 22.23 Vanrx Pharmasystems: Company Overview
Table 22.24 Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
Table 22.25 Key Specifications of SA25 Aseptic Filling Workcell
Table 24.1 Jinan Youlyy Industrial: Company Snapshot
Table 24.2 Sagar Rubber: Company Snapshot
Table 24.3 Aseptic Technologies: Company Snapshot
Table 24.4 BioPhorum Operations: Company Snapshot
Table 24.5 PYRAMID Laboratories: Company Snapshot
Table 25.1 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Container
Table 25.2 Pre-Sterilized / Ready to Use Containers: Distribution by Material(s) of Fabrication
Table 25.3 Pre-Sterilized / Ready to Use Containers: Distribution by Container Color
Table 25.4 Pre-Sterilized / Ready to Use Containers: Distribution by Type of Compatible Drug(s)
Table 25.5 Pre-Sterilized / Ready to Use Containers: Distribution by Scale of Operation
Table 25.6 Pre-Sterilized / Ready to Use Containers: Distribution by Packaging Format(s)
Table 25.7 Pre-Sterilized / Ready to Use Containers: Distribution by Sterilization Technique(s) Used
Table 25.8 Pre-Sterilized / Ready to Use Containers: Distribution by Quality Certification(s) Obtained
Table 25.9 Pre-Sterilized / Ready to Use Containers: Distribution by Target Market
Table 25.10 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of Additional Coating
Table 25.11 Pre-Sterilized / Ready to Use Containers: Distribution by Availability of RTU Kits
Table 25.12 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Year of Establishment
Table 25.13 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Company Size
Table 25.14 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 25.15 Pre-Sterilized / Ready to Use Container Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 25.16 Leading Manufacturers: Distribution by Number of Products
Table 25.17 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Closure
Table 25.18 Pre-Sterilized / Ready to Use Closures: Distribution by Material(s) of Fabrication
Table 25.19 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Container(s)
Table 25.20 Pre-Sterilized / Ready to Use Closures: Distribution by Type of Compatible Drug(s)
Table 25.21 Pre-Sterilized / Ready to Use Closures: Distribution by Sterilization Technique(s) Used
Table 25.22 Pre-Sterilized / Ready to Use Closures: Distribution by Available Finish Format(s)
Table 25.23 Pre-Sterilized / Ready to Use Closures: Distribution by Quality Certification(s) Obtained
Table 25.24 Pre-Sterilized / Ready to Use Closures: Distribution by Target Market
Table 25.25 Pre-Sterilized / Ready to Use Closures: Distribution by Availability of Additional Coating
Table 25.26 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Year of Establishment
Table 25.27 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Company Size
Table 25.28 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 25.29 Pre-Sterilized / Ready to Use Closure Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 25.30 Leading Manufacturers: Distribution by Number of Products
Table 25.31 Key Insights: Distribution by Type of Container and Scale of Operation
Table 25.32 Key Insights: Distribution by Type of Container and Packaging Format(s)
Table 25.33 Key Insights: Distribution by Type of Container and Material(s) of Fabrication
Table 25.34 Key Insights: Distribution by Type of Container and Container Color
Table 25.35 Key Insights: Distribution by Type of Container and Sterilization Technique(s) Used
Table 25.36 Key Insights: Distribution by Type of Container and Type of Compatible Drug(s)
Table 25.37 Key Insights: Distribution by Material(s) of Fabrication and Sterilization Technique(s) Used
Table 25.38 Key Insights: Distribution by Type of Closure and Material(s) of Fabrication
Table 25.39 Key Insights: Distribution by Type of Closure and Sterilization Technique(s) Used
Table 25.40 Key Insights: Distribution by Type of Closure and Available Finish Format(s)
Table 25.41 Key Insights: Distribution by Type of Closure and Type of Compatible Drug(s)
Table 25.42 Aptar: Annual Revenues, 2016-Q1 2023 (USD Billion)
Table 25.43 Datwyler: Annual Revenues, 2016-2022 (CHF Billion)
Table 25.44 SCHOTT: Annual Revenues, FY 2019-FY 2022 (EUR Billion)
Table 25.45 West Pharmaceutical Services: Annual Revenues, 2018-2022 (USD Billion)
Table 25.46 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2023
Table 25.47 Partnerships and Collaborations: Distribution by Type of Partnership
Table 25.48 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Table 25.49 Partnerships and Collaborations: Distribution by Type of Partner
Table 25.50 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner, 2015-2023
Table 25.51 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 25.52 Partnerships and Collaborations: Distribution by Purpose(s) of Partnership
Table 25.53 Partnerships and Collaborations: Distribution by Type of Packaging System
Table 25.54 Partnerships and Collaborations: Distribution by Type of Packaging Material
Table 25.55 Most Active Players: Distribution by Number of Partnerships
Table 25.56 Partnerships and Collaborations: Local and International Agreements
Table 25.57 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 25.58 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Type of Container
Table 25.59 Demand for Pre-Sterilized / Ready to Use Vials, 2023-2035
Table 25.60 Demand for Pre-Sterilized / Ready to Use Syringes, 2023-2035
Table 25.61 Demand for Pre-Sterilized / Ready to Use Cartridges, 2023-2035
Table 25.62 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Type of Closure
Table 25.63 Demand for Pre-Sterilized / Ready to Use Caps, 2023-2035
Table 25.64 Demand for Pre-Sterilized / Ready to Use Plungers, 2023-2035
Table 25.65 Demand for Pre-Sterilized / Ready to Use Seals, 2023-2035
Table 25.66 Demand for Pre-Sterilized / Ready to Use Stoppers, 2023-2035
Table 25.67 Demand for Pre-Sterilized / Ready to Use Tip Caps / Needle Shields, 2023-2035
Table 25.68 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Material of Fabrication
Table 25.69 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Aluminum Containers and Closures, 2023-2035
Table 25.70 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Glass Containers and Closures, 2023-2035
Table 25.71 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Plastic Containers and Closures, 2023-2035
Table 25.72 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging for Rubber Containers and Closures, 2023-2035
Table 25.73 Global Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging, 2023-2035: Distribution by Geography
Table 25.74 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in North America, 2023-2035
Table 25.75 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Europe, 2023-2035
Table 25.76 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Asia, 2023-2035
Table 25.77 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Latin America, 2023-2035
Table 25.78 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Middle East and North Africa, 2023-2035
Table 25.79 Demand for Pre-Sterilized / Ready to Use Pharmaceutical Packaging in Rest of the World, 2023-2035
Table 25.80 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.81 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035: Optimistic Scenario
Table 25.82 Global Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market, 2023-2035: Conservative Scenario
Table 25.83 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Vials: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.84 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Syringes: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.85 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Cartridges: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.86 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Caps: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.87 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plungers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.88 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Seals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.89 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Stoppers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.90 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Tip Caps / Needle Shields: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.91 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Aluminum Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.92 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Glass Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (20232035)
Table 25.93 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Plastic Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.94 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Rubber Containers and Closures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.95 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.96 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.97 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.98 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.99 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.100 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.101 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.102 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.103 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Asia: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.104 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.105 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.106 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.107 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.108 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.109 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.110 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.111 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Containers in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Table 25.112 Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market for Closures in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
The following companies / institutes / government bodies and organizations have been mentioned in this report:
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
SUBSCRIBE TO INDUSTRY UPDATES